Puma Biotechnology, Inc. (PBYI) Falls on Dely of New Drug Application

Shares of Los Angeles, California, based Puma Biotechnology, Inc. (PBYI) fell sharlply on Tuesday, against the backrop of a generally higher day in stocks overall. Puma's stock was down 21.06%, falling $7.45 per share, to close at $27.92, on volume of 4,184,129 shares. The company's stock fell as a result of an announcement late Monday ... READ MORE Read the rest of Puma Biotechnology, Inc. (PBYI) Falls on Dely of New Drug Application at InvestorGuide.com .